Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
23.92 USD | +0.08% | -0.58% | +213.50% |
Apr. 08 | Canaccord Genuity Adjusts Price Target on CervoMed to $65 From $50, Maintains Buy Rating | MT |
Mar. 29 | CervoMed Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Chart calendar CervoMed Inc.
Upcoming events on CervoMed Inc.
No events available
Past events on CervoMed Inc.
2024-04-17 | Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference |
2024-04-11 12:45 pm | Needham Healthcare Conference |
2024-04-04 09:40 am | MedInvest Biotech & Pharma Investor Conference |
2024-04-03 03:25 pm | Emerging Growth Conference |
2024-04-01 08:00 am | Q4 2023 Earnings Release |
2024-03-07 11:30 am | Alzheimers and Parkinsons Diseases International Conference - Panel |
2024-03-04 | Alzheimer and Parkinson Diseases International Conference - Abstract No:2438 |
2024-03-04 | Alzheimer and Parkinson Diseases International Conference - Abstract No:1095 |
2024-02-26 02:00 pm | BIO CEO & Investor Conference |
2024-02-07 03:50 pm | Emerging Growth Conference |
2024-01-11 11:25 am | Emerging Growth Conference |
2023-11-13 07:00 am | Q3 2023 Earnings Release |
2023-10-25 02:50 pm | Alzheimer Disease Clinical Trials Conference |
2023-10-12 01:00 pm | Roth Healtcare Opportunities Conference |
2023-09-11 09:00 am | H.C. Wainwright Global Investment Conference |
2023-08-16 | Reverse Split: 1 of 1.5 |
2023-08-09 04:00 pm | Canaccord Genuity Growth Conference |
Annual results
Fiscal Period | December | 2022 | 2023 | 2024 |
---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 | 7,14 4,35 64.25% | 8,40 |
EBITDA Million USD | Released Forecast Spread | 0,00 | 0,00 -14,4 - | -14,7 |
EBIT Million USD | Released Forecast Spread | 0,00 | -7,81 -16,9 53.77% | -13,0 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -2,17 -14,3 84.81% | -12,5 |
Net income Million USD | Released Forecast Spread | -5,80 | -2,17 -14,3 84.81% | -12,5 |
EPS USD | Released Forecast Spread | -1,29 | -0,82 -3,57 77% | -1,37 |
Announcement Date | 13/07/23 | 29/03/24 | - |
Quarterly results
Fiscal Period | December | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 1,53 0,00 - | 2,49 1,00 149.06% | 2,35 | 2,00 | 2,00 | 2,00 |
EBITDA Million USD | Released Forecast Spread | -1,50 | -2,20 | -3,40 | -4,40 | -4,90 | |
EBIT Million USD | Released Forecast Spread | -2,68 -5,40 50.46% | -2,48 -3,70 32.96% | -3,25 | -4,00 | -3,70 | -4,05 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 2,15 -5,40 139.82% | -2,36 -3,65 35.28% | -3,15 | -3,90 | -3,55 | -3,90 |
Net income Million USD | Released Forecast Spread | 2,15 -5,40 139.82% | -2,36 -3,65 35.28% | -3,15 | -3,90 | -3,55 | -3,90 |
EPS USD | Released Forecast Spread | 0,65 -0,95 168.42% | -0,95 -0,62 -53.23% | -0,39 | -0,42 | -0,38 | -0,41 |
Announcement Date | 13/11/23 | 29/03/24 | - | - | - | - |
Past sector events for CervoMed Inc.
Today | TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release (Projected) |
2024-05-09 04:15 pm | ANAPTYSBIO, INC.: Q1 2024 Earnings Release |
2024-05-09 04:10 pm | ASTRIA THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-09 04:09 pm | XENCOR, INC.: Q1 2024 Earnings Release |
2024-05-09 04:02 pm | SPYRE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-09 04:01 pm | MACROGENICS, INC.: Q1 2024 Earnings Release |
2024-05-09 04:01 pm | ARROWHEAD PHARMACEUTICALS, INC.: Q2 2024 Earnings Release |
2024-05-09 04:00 pm | ALX ONCOLOGY HOLDINGS INC.: Q1 2024 Earnings Release |
2024-05-09 08:00 am | FRAZIER LIFESCIENCES ACQUISITION CORPORATION: Q1 2024 Earnings Release |
2024-05-09 07:30 am | WAVE LIFE SCIENCES LTD.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- CRVO Stock
- Calendar CervoMed Inc.